Cargando…
Evaluation of prophylactic dosages of Enoxaparin in non-surgical elderly patients with renal impairment
BACKGROUND: Thromboprophylaxis dosing strategies using enoxaparin in elderly patients with renal disease are limited, while dose adjustments or monitoring of anti-Xa levels are recommended. We sought to evaluate the efficacy and safety of enoxaparin 20 mg versus 30 mg subcutaneously daily by compari...
Autores principales: | Chamoun, Nibal, Ghanem, Hady, Hachem, Ahmad, Hariri, Essa, Lteif, Christelle, Mansour, Hanine, Dimassi, Hani, Zalloum, Richard, Ghanem, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505244/ https://www.ncbi.nlm.nih.gov/pubmed/31064405 http://dx.doi.org/10.1186/s40360-019-0308-8 |
Ejemplares similares
-
Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
por: Karaoui, Lamis R., et al.
Publicado: (2018) -
The Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Cardiovascular Homeostasis: A Non-Systematic Literature Review
por: Hachem, Ahmad, et al.
Publicado: (2017) -
Burnout and coping strategies among health system pharmacists in Lebanon: a cross-sectional study
por: Abilmona, Rosa, et al.
Publicado: (2023) -
Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
por: Matli, Kamal, et al.
Publicado: (2021) -
A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs)
por: Chamoun, Nibal, et al.
Publicado: (2019)